Jennifer Bennett, managing director and associate general counsel in the Office of the Corporate Secretary for Bank of America Corporation in Charlotte, North Carolina, has been appointed Chair of the Breakthrough T1D Global Mission Board (GMB), effective July 1, 2022.
The Breakthrough T1D GMB also welcomes new members Meredith Coors (Mountain West Chapter), Laura Cramer (Mid-Atlantic Chapter), Maarten de Groot (Breakthrough T1D Netherlands), Gwen Malone (Pacific Northwest Chapter) and David Schwab (Mid-Atlantic Chapter), to help drive mission progress through volunteer engagement.
The Breakthrough T1D GMB, created in 2019, is a group of volunteer leaders who collaborate with staff leaders to advance Breakthrough T1D’s mission through special initiatives in research, advocacy, fundraising, and community engagement. Jennifer will be the second-ever Chair of the GMB, following Kim Roosevelt, who served in the role for the last three years.
Vanguard Volunteer
Jennifer became part of Breakthrough T1D 17 years ago when her child, Rain, was diagnosed with type 1 diabetes (T1D) at the age of three. Her family has participated in the Breakthrough T1D One Walk every year since Rain’s diagnosis.
Jennifer’s dedication to Breakthrough T1D is unmistakable. Jennifer has volunteered in many roles in Breakthrough T1D’s North Carolina Chapter, including as Chapter Board President and Executive Council Chair. At the national level, she previously served on the International Board of Directors (IBOD) and is currently on the IBOD’s Nominating and Governance Committee and the Talent and Compensation Committee. She has been a member of the GMB’s leadership since 2019, heading the fundraising and engagement pillar.
“Our Global Mission Board plays a critical role in Breakthrough T1D’s Mission and in recruiting and engaging volunteers,” said Aaron J. Kowalski, Ph.D., Breakthrough T1D Chief Executive Officer. “I’m confident that our GMB, together with Jennifer and its newest board members, will harness the passion of our volunteers to accelerate our mission progress and move us even closer to a world without T1D.”
